Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects
| Class:Id | LiteratureReference:9015353 |
| _displayName | The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects |
| _timestamp | 2017-08-10 09:56:30 |
| author | [Person:9015359] Stangier, Joachim [Person:9015374] Rathgen, Karin [Person:9015378] Stähle, Hildegard [Person:9015364] Gansser, Dietmar [Person:9015362] Roth, Willy |
| created | [InstanceEdit:9015363] Jassal, Bijay, 2017-08-10 |
| journal | Br J Clin Pharmacol |
| pages | 292-303 |
| pubMedIdentifier | 17506785 |
| title | The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects |
| volume | 64 |
| year | 2007 |
| (literatureReference) | [Reaction:9015379] Factor IIa inhibitors (compounds) binds IIa [Homo sapiens] [ChemicalDrug:9015346] dabigatran [extracellular region] [Summation:9026994] In the blood coagulation process, prothrombin is proteolytic... [Summation:9026996] In the blood coagulation process, prothrombin is proteolytic... [Summation:9026997] In the blood coagulation process, prothrombin is proteolytic... [Summation:9026998] In the blood coagulation process, prothrombin is proteolytic... [Summation:9603336] Some direct oral anticoagulant (DOAC) drugs are potent, comp... |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects (9015353)